Holen Sie sich die Stockscreener-App
3.87
0.26%
-0.010
Handel nachbörslich:
3.84
-0.03
-0.78%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LFMD?
Forum
Prognose
Aktiensplit
Lifemd Inc Aktie (LFMD) Neueste Nachrichten
Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers say - STAT
FEDERATED HERMES, INC. Acquires Significant Stake in LifeMD Inc - GuruFocus
LFMD News | LIFEMD INC (NASDAQ:LFMD) - ChartMill
LifeMD Inc. (LFMD) Declines 1.9%, Testing Key Support Near $4.41Volume Climax - dars.gov.et
B. Riley Names Top Digital Health Stock to Buy By Investing.com - Investing.com Australia
B. Riley Names Top Digital Health Stock to Buy - Investing.com India
LifeMD Rings the Nasdaq Stock Market Closing Bell - Nasdaq
LifeMD Rings the Closing Bell - Nasdaq
Federated Hermes reports 2.75M-share stake in LifeMD (LFMD) - Stock Titan
LifeMD Inc. (LFMD) Q1 2026 Earnings: EPS Beats Estimates Amid Revenue Disclosure GapConsensus Miss Rate - dars.gov.et
LifeMD, Inc. (NASDAQ:LFMD): Can the Penny Stock Story Continue? - Kalkine Media
LFMDP Q1 2026 Earnings: Narrower-Than-Expected Loss Sends Preferred Stock Slightly LowerGuidance Accuracy Score - dars.gov.et
Undiscovered Opportunities Penny Stocks To Consider In July 2026 - Sahm
(LFMD) Volatility Zones as Tactical Triggers - Stock Traders Daily
LFMDP Q1 2026 Earnings: Narrower Loss Surprises as Preferred Stock DeclinesEarnings Call Transcript - dars.gov.et
LifeMD Inc. (LFMDP) Q1 2026 Earnings: Preferred Shares Dip Despite Narrower-Than-Expected LossRevenue Guidance Range - dars.gov.et
LFMD Q1 2026 Earnings: EPS Surpasses Estimates Despite Lack of Revenue DisclosureEarnings Yield Spread - dars.gov.et
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion By Investing.com - Investing.com South Africa
B. Riley Securities Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $10 - Moomoo
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion - Investing.com
LifeMD Inc. (LFMD) Q1 2026 Earnings: EPS Beat Partially Offsets Revenue UncertaintyTangible Book Value - dars.gov.et
LFMD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
LFMD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
LifeMD Inc. (LFMD) Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Improved Cost DisciplineConsensus Beat Rate - dars.gov.et
LFMDP Q1 2026 Earnings: Preferred Stock Benefiting from Improved Operational Performance as Loss Narrower Than ExpectedQuarterly Earnings Report - dars.gov.et
Enterprise value to revenue forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
Price to book forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
Price to sales forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On July 2nd, 2026 With 0.55469 USD Dividend Per Share - 富途牛牛
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
Best GLP-1 Medical Weight Loss Clinics in 2026 | Good Life Health - marketscreener.com
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection - Sahm
LifeMD, Inc. And Antares Pharma, Inc. Launch Direct-To-Patient Self-Pay Program For XYOSTED (Testosterone Enanthate) Injection - marketscreener.com
LifeMD Partners with Antares on XYOSTED Telehealth Program - TipRanks
LifeMD partners with Antares Pharma on testosterone program By Investing.com - Investing.com Nigeria
Form 8K LifeMD Inc For: 22 June By Investing.com - Investing.com South Africa
LifeMD partners with Antares Pharma on testosterone program - Investing.com
LifeMD to Launch Exclusive XYOSTED Self-Pay Telehealth Program in July across 37 States - TradingView
LifeMD (Nasdaq: LFMD) inks exclusive telehealth collaboration for XYOSTED self-pay program - Stock Titan
LifeMD and Halozyme Announce Exclusive Telehealth Co-Marketing Agreement for XYOSTED Self-Pay Program Launching in July 2026 - Quiver Quantitative
LifeMD, Halozyme link up to sell testosterone therapy online - Stock Titan
LifeMD Inc (LFMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LifeMD Inc (LFMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LifeMD Inc (LFMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LifeMD Inc (LFMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
LifeMD Inc (LFMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LifeMD Inc (LFMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LifeMD Inc (LFMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LifeMD Inc (LFMD) Institutional Confidence - TradingKey
LifeMD Inc (LFMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LifeMD (LFMD) Sheds Value: Testing Near-Term Support After 1.83% DeclineATR Stop - DonanımHaber
1.57%
1.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):